Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18584 | 479 | 35.2 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MIA | Author keyword | 15 | 37% | 7% | 32 |
| 2 | CIRCULATING MELANOMA CELLS | Author keyword | 15 | 73% | 2% | 11 |
| 3 | MELANOMA INHIBITORY ACTIVITY | Author keyword | 13 | 62% | 3% | 13 |
| 4 | TYROSINASE MRNA | Author keyword | 12 | 75% | 2% | 9 |
| 5 | CD RAP | Author keyword | 11 | 78% | 1% | 7 |
| 6 | SERUM S100 PROTEIN | Author keyword | 9 | 83% | 1% | 5 |
| 7 | MELANOMA INHIBITING ACTIVITY | Author keyword | 8 | 100% | 1% | 5 |
| 8 | MELANOMA INHIBITORY ACTIVITY MIA | Author keyword | 6 | 100% | 1% | 4 |
| 9 | DERMATOL B | Address | 4 | 75% | 1% | 3 |
| 10 | MIA CD RAP | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MIA | 15 | 37% | 7% | 32 | Search MIA | Search MIA |
| 2 | CIRCULATING MELANOMA CELLS | 15 | 73% | 2% | 11 | Search CIRCULATING+MELANOMA+CELLS | Search CIRCULATING+MELANOMA+CELLS |
| 3 | MELANOMA INHIBITORY ACTIVITY | 13 | 62% | 3% | 13 | Search MELANOMA+INHIBITORY+ACTIVITY | Search MELANOMA+INHIBITORY+ACTIVITY |
| 4 | TYROSINASE MRNA | 12 | 75% | 2% | 9 | Search TYROSINASE+MRNA | Search TYROSINASE+MRNA |
| 5 | CD RAP | 11 | 78% | 1% | 7 | Search CD+RAP | Search CD+RAP |
| 6 | SERUM S100 PROTEIN | 9 | 83% | 1% | 5 | Search SERUM+S100+PROTEIN | Search SERUM+S100+PROTEIN |
| 7 | MELANOMA INHIBITING ACTIVITY | 8 | 100% | 1% | 5 | Search MELANOMA+INHIBITING+ACTIVITY | Search MELANOMA+INHIBITING+ACTIVITY |
| 8 | MELANOMA INHIBITORY ACTIVITY MIA | 6 | 100% | 1% | 4 | Search MELANOMA+INHIBITORY+ACTIVITY+MIA | Search MELANOMA+INHIBITORY+ACTIVITY+MIA |
| 9 | MIA CD RAP | 3 | 100% | 1% | 3 | Search MIA+CD+RAP | Search MIA+CD+RAP |
| 10 | MIA MELANOMA INHIBITING ACTIVITY | 3 | 100% | 1% | 3 | Search MIA+MELANOMA+INHIBITING+ACTIVITY | Search MIA+MELANOMA+INHIBITING+ACTIVITY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TYROSINASE MESSENGER RNA | 42 | 51% | 12% | 59 |
| 2 | CIRCULATING NEOPLASTIC CELLS | 23 | 86% | 3% | 12 |
| 3 | RELIABLE TUMOR MARKER | 21 | 90% | 2% | 9 |
| 4 | MELANOMA INHIBITORY ACTIVITY | 17 | 51% | 5% | 24 |
| 5 | MIA | 15 | 53% | 4% | 20 |
| 6 | ACTIVITY MIA | 15 | 71% | 3% | 12 |
| 7 | ACID SENSITIVE PROTEIN | 11 | 69% | 2% | 9 |
| 8 | INHIBITORY ACTIVITY MIA | 10 | 73% | 2% | 8 |
| 9 | CD RAP | 6 | 100% | 1% | 4 |
| 10 | MIA CD RAP | 4 | 75% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The prognostic value of circulating tumor cells in patients with melanoma: A systematic review and meta-analysis | 2006 | 84 | 62 | 84% |
| Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance | 2015 | 2 | 38 | 34% |
| Serological markers for melanoma | 2000 | 77 | 91 | 74% |
| Expression, function and clinical relevance of MIA (Melanoma Inhibitory Activity) | 2002 | 32 | 33 | 94% |
| Detection methods of circulating tumor cells in cutaneous melanoma: A systematic review | 2014 | 4 | 141 | 44% |
| Circulating Serologic and Molecular Biomarkers in Malignant Melanoma | 2011 | 19 | 116 | 47% |
| Molecular markers of circulating melanoma cells | 2007 | 31 | 100 | 51% |
| Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression | 2005 | 27 | 33 | 73% |
| Old and new serological biomarkers in melanoma: where we are in 2009 | 2010 | 12 | 95 | 51% |
| The current status of S-100B as a biomarker in melanoma | 2012 | 7 | 21 | 48% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DERMATOL B | 4 | 75% | 0.6% | 3 |
| 2 | N MEM HLTH CARE | 2 | 67% | 0.4% | 2 |
| 3 | ORTHOPAED CELL BIOL PHYSIOL | 2 | 67% | 0.4% | 2 |
| 4 | CELL BIOL IMMUNOL EXPT ONCOL | 1 | 100% | 0.4% | 2 |
| 5 | ENDOONCO S | 1 | 50% | 0.4% | 2 |
| 6 | SERV DERMATOL B | 1 | 100% | 0.4% | 2 |
| 7 | CLIN MALATIES HEMATOL ONCOL | 1 | 50% | 0.2% | 1 |
| 8 | ECU MELANOMA FDN | 1 | 50% | 0.2% | 1 |
| 9 | EUROPEAN ORG | 1 | 50% | 0.2% | 1 |
| 10 | KLINIKEN ALLGEMEIN VISZERALCHIRURG | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000167580 | THIN MELANOMA//SENTINEL LYMPH NODE//SYDNEY MELANOMA UNIT |
| 2 | 0.0000146272 | MYXOID TISSUE//S 100A//S100 ALPHA PROTEIN |
| 3 | 0.0000107355 | BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE |
| 4 | 0.0000107003 | CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//CIRCULATING TUMOUR CELLS |
| 5 | 0.0000080487 | GICERIN//CD146//NEURITE OUTGROWTH FACTOR |
| 6 | 0.0000071715 | S 100B//S 100B PROTEIN//NEURON SPECIFIC ENOLASE |
| 7 | 0.0000065573 | EUMELANIN//PHEOMELANIN//MELANIN |
| 8 | 0.0000049257 | DICER//DROSHA//MICROPROCESSOR COMPLEX |
| 9 | 0.0000047836 | SPITZ NEVUS//DESMOPLASTIC MELANOMA//MALIGNANT BLUE NEVUS |
| 10 | 0.0000044146 | MELANOGENESIS//MITF//TYROSINASE |